← FDA Drug Approvals (Drugs@FDA)
TREPROSTINIL
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SANDOZ · Approved 2017-11-30
Drug application
- FDA Application #
ANDA203649- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- TREPROSTINIL
- Generic name
- TREPROSTINIL
- Active ingredients
- TREPROSTINIL
- Dosage form
- INJECTABLE
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Marketing status
- Prescription
- Sponsor
- SANDOZ
- Manufacturer
- Sandoz Inc
- First approval
- 2017-11-30
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown